Ascendis Pharma (ASND) has released an update.
Ascendis Pharma A/S, a Danish biopharmaceutical company, has entered into an underwriting agreement with major investment banks such as J.P. Morgan Securities LLC and Goldman Sachs & Co. LLC for the sale of 2 million American Depositary Shares (ADSs), with an option for underwriters to purchase an additional 300,000 ADSs. This move is aimed at facilitating a public offering of these securities, as detailed in a registration statement filed with the U.S. Securities and Exchange Commission. The company plans to make the public offering soon after the execution and delivery of the agreement.
For further insights into ASND stock, check out TipRanks’ Stock Analysis page.